Literature DB >> 21353790

Single-centre 40-year results of redo operation for recurrent thymomas.

Stefano Margaritora1, Alfredo Cesario, Giacomo Cusumano, Filippo Lococo, Venanzio Porziella, Elisa Meacci, Amelia Evoli, Pierluigi Granone.   

Abstract

OBJECTIVE: Modes of treatment for recurrent thymoma remain controversial. The aim of this study is to analyse the early and long-term results of surgical intervention for this condition.
METHODS: Between 1972 and 2008, 43 out of 315 patients, who underwent resection with radical intent for thymoma, subsequently relapsed. Of these, 30 cases were deemed suitable for resection and operation, and were surgically treated. The remaining 13 were treated with radio- and/or chemotherapy (RT/CT). Overall outcomes for long-term survival up to 5 years (LTS) and disease-free survival (DFS) were analysed using standard statistics.
RESULTS: The average age of the relapsed patients was 54.7±12.7 years. There were 21 males and 22 females. Forty out of the 43 had myasthenia gravis (MG). Fifteen cases concerned a single detected relapse lesion. Among the 43 patients, relapses were found in the following sites: pleura (25 cases), mediastinum (12), lung (five), liver and bone (one). The perioperative mortality was 0% and the morbidity was 27%. Twenty-two of the surgically treated patients had complete resection; their LTS was 77% and DFS was 71%. Those patients who underwent surgery had significantly better outcomes compared with patients treated with radio- and/or chemotherapy (LTS only 35%; hazard ratio (HR): 0.22; 95% confidence interval (CI): 0.08-0.59; p=0.001). Complete repeated resection yielded much better outcomes than partial resection (LTS 91% vs 31%, p<0.001), whereas incomplete resection was associated, as one might expect, with a poor prognosis (HR: 6.12; 95% CI: 1.18-31.55; p=0.031). No evidence for an association with other clinical, surgical and pathological characteristics was found with regard to LTS or DFS.
CONCLUSIONS: Surgical resection is recommended for the treatment of recurrent thymoma, provided that criteria for suitability for resection/operation are satisfactory at the time of diagnosis. Best survival outcomes are found to depend on the degree of completeness of the repeat resection.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21353790     DOI: 10.1016/j.ejcts.2011.01.025

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  14 in total

1.  Video assisted thoracic surgery (VATS) for recurrent thymoma.

Authors:  Giuseppe Marulli; Giovanni Maria Comacchio; Federico Rea
Journal:  Ann Cardiothorac Surg       Date:  2015-11

2.  Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression.

Authors:  Giuseppe L Banna; Ankur Sheel; Varun Sheel; Andrea Bille; Tom Routledge; Shalini Fernando; Arjun Nair; Rohit Lal
Journal:  Future Oncol       Date:  2017-11-10       Impact factor: 3.404

3.  Editorial: pleural recurrence of thymoma-what is the value of intra-thoracic chemo-hyperthermia?

Authors:  Anja C Roden; Julian R Molina
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Surgical treatment of single and multiple thymoma recurrences.

Authors:  Angelo Carretta; Paola Ciriaco; Piergiorgio Muriana; Alessandro Bandiera; Giampiero Negri
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-10-22

5.  Minimally invasive thymectomy: the Mayo Clinic experience.

Authors:  Phillip G Rowse; Anja C Roden; Frank M Corl; Mark S Allen; Stephen D Cassivi; Francis C Nichols; K Robert Shen; Dennis A Wigle; Shanda H Blackmon
Journal:  Ann Cardiothorac Surg       Date:  2015-11

6.  A new application for argon beam coagulation: the thymoma patient with pleural recurrence.

Authors:  Yen-Chiang Tseng; Yen-Han Tseng; En-Kuei Tang; Yih-Gang Goan
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

7.  Stage-based treatment for thymoma in due consideration of thymectomy: a single-center experience and comparison with the literature.

Authors:  Joerg Lindenmann; Nicole Fink-Neuboeck; Martin Pichler; Udo Anegg; Alfred Maier; Josef Smolle; Freyja Maria Smolle-Juettner
Journal:  World J Surg Oncol       Date:  2015-10-16       Impact factor: 2.754

Review 8.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

9.  Long-term outcomes of 307 patients after complete thymoma resection.

Authors:  Zu-Yang Yuan; Shu-Geng Gao; Ju-Wei Mu; Qi Xue; You-Sheng Mao; Da-Li Wang; Jun Zhao; Yu-Shun Gao; Jin-Feng Huang; Jie He
Journal:  Chin J Cancer       Date:  2017-05-15

10.  Surgical outcomes of 215 patients with thymic epithelial tumors: A single-center experience.

Authors:  Wenxin Tian; Yaoguang Sun; Qingjun Wu; Peng Jiao; Chao Ma; Hanbo Yu; Chuan Huang; Hongfeng Tong
Journal:  Thorac Cancer       Date:  2020-05-08       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.